FWP
XBI icon

FAS Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FAS Wealth Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.6K Sell
522
-283
-35% -$38.3K ﹤0.01% 389
2026
Q1 		$103K Hold
805
– – 0.01% 366
2025
Q4 		$98.1K Buy
805
+1
+0.1% +$115 0.01% 366
2025
Q3 		$80.6K Hold
804
– – 0.01% 351
2025
Q2 		$66.7K Sell
804
-3,555
-82% -$284K ﹤0.01% 356
2025
Q1 		$354K Hold
4,359
– – 0.03% 244
2024
Q4 		$393K Hold
4,359
– – 0.03% 233
2024
Q3 		$431K Sell
4,359
-70
-2% -$6.88K 0.03% 225
2024
Q2 		$411K Hold
4,429
– – 0.04% 224
2024
Q1 		$420K Hold
4,429
– – 0.04% 222
2023
Q4 		$395K Buy
4,429
+2,540
+134% +$189K 0.04% 221
2023
Q3 		$138K Hold
1,889
– – 0.01% 285
2023
Q2 		$157K Hold
1,889
– – 0.02% 265
2023
Q1 		$144K Buy
1,889
+134
+8% +$11.1K 0.02% 294
2022
Q4 		$146K Buy
1,755
+995
+131% +$80.6K 0.02% 287
2022
Q3 		$60K Buy
760
+126
+20% +$10.6K 0.01% 313
2022
Q2 		$47K Hold
634
– – ﹤0.01% 325
2022
Q1 		$57K Buy
634
+44
+7% +$4.06K 0.01% 322
2021
Q4 		$66K Hold
590
– – 0.01% 328
2021
Q3 		$74K Hold
590
– – 0.01% 324
2021
Q2 		$80K Sell
590
-350
-37% -$46K 0.01% 306
2021
Q1 		$128K Buy
940
+90
+11% +$13.5K 0.01% 271
2020
Q4 		$120K Hold
850
– – 0.01% 261
2020
Q3 		$95K Hold
850
– – 0.01% 252
2020
Q2 		$95K Hold
850
– – 0.01% 239
2020
Q1 		$66K Buy
+850
New +$75.3K 0.01% 238

Other funds holding XBI

PR
PSP Research Newtown Square, Pennsylvania $188M AUM
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
WTC
WhitTier Trust Company Reno, Nevada $5.35B AUM 29.91% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

FAS Wealth Partners's XBI Position: Q2 2026 in Review

FAS Wealth Partners reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 35% in Q2 2026, selling an estimated $38.3K and leaving 522 shares worth $82.6K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

FAS Wealth Partners first reported a position in XBI in Q1 2020 and has held it in 26 quarters since. The position peaked at $431K in Q3 2024. 334 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • FAS Wealth Partners held 522 shares of State Street SPDR S&P Biotech ETF worth $82.6K as of Q2 2026.
  • FAS Wealth Partners sold 283 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $38.3K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of FAS Wealth Partners's portfolio in Q2 2026, its #389 holding.
  • FAS Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 26 quarters since.
  • FAS Wealth Partners's State Street SPDR S&P Biotech ETF position peaked at $431K in Q3 2024.
  • 334 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.